Cargando…

New Devices in Glaucoma

Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Lilian, Moster, Marlene R., Bicket, Amanda K., Sheybani, Arsham, Sarkisian, Steven R., Samuelson, Thomas W., Ahmed, Iqbal Ike K., Miller-Ellis, Eydie, Smith, Oluwatosin U., Cui, Qi N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441989/
https://www.ncbi.nlm.nih.gov/pubmed/37558818
http://dx.doi.org/10.1007/s40123-023-00780-3
_version_ 1785093489649778688
author Chan, Lilian
Moster, Marlene R.
Bicket, Amanda K.
Sheybani, Arsham
Sarkisian, Steven R.
Samuelson, Thomas W.
Ahmed, Iqbal Ike K.
Miller-Ellis, Eydie
Smith, Oluwatosin U.
Cui, Qi N.
author_facet Chan, Lilian
Moster, Marlene R.
Bicket, Amanda K.
Sheybani, Arsham
Sarkisian, Steven R.
Samuelson, Thomas W.
Ahmed, Iqbal Ike K.
Miller-Ellis, Eydie
Smith, Oluwatosin U.
Cui, Qi N.
author_sort Chan, Lilian
collection PubMed
description Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management.
format Online
Article
Text
id pubmed-10441989
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-104419892023-08-22 New Devices in Glaucoma Chan, Lilian Moster, Marlene R. Bicket, Amanda K. Sheybani, Arsham Sarkisian, Steven R. Samuelson, Thomas W. Ahmed, Iqbal Ike K. Miller-Ellis, Eydie Smith, Oluwatosin U. Cui, Qi N. Ophthalmol Ther Review Glaucoma remains a leading cause of blindness globally. Minimally invasive treatment techniques are rapidly expanding the availability of therapeutic options for glaucoma. These include devices aimed at enhancing outflow through the subconjunctival space, Schlemm’s canal, and suprachoroidal space, sustained-release drug delivery devices, and extraocular devices aiming to reduce glaucomatous progression through other novel means. In this review, we provide an overview of several novel devices either newly available or in development for the medical and surgical management of glaucoma. Further studies are required to determine the long-term efficacy of these devices and how they will integrate into the current landscape of glaucoma management. Springer Healthcare 2023-08-09 2023-10 /pmc/articles/PMC10441989/ /pubmed/37558818 http://dx.doi.org/10.1007/s40123-023-00780-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Chan, Lilian
Moster, Marlene R.
Bicket, Amanda K.
Sheybani, Arsham
Sarkisian, Steven R.
Samuelson, Thomas W.
Ahmed, Iqbal Ike K.
Miller-Ellis, Eydie
Smith, Oluwatosin U.
Cui, Qi N.
New Devices in Glaucoma
title New Devices in Glaucoma
title_full New Devices in Glaucoma
title_fullStr New Devices in Glaucoma
title_full_unstemmed New Devices in Glaucoma
title_short New Devices in Glaucoma
title_sort new devices in glaucoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441989/
https://www.ncbi.nlm.nih.gov/pubmed/37558818
http://dx.doi.org/10.1007/s40123-023-00780-3
work_keys_str_mv AT chanlilian newdevicesinglaucoma
AT mostermarlener newdevicesinglaucoma
AT bicketamandak newdevicesinglaucoma
AT sheybaniarsham newdevicesinglaucoma
AT sarkisianstevenr newdevicesinglaucoma
AT samuelsonthomasw newdevicesinglaucoma
AT ahmediqbalikek newdevicesinglaucoma
AT millerelliseydie newdevicesinglaucoma
AT smitholuwatosinu newdevicesinglaucoma
AT cuiqin newdevicesinglaucoma